ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 253 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,343,900 | -35.7% | 635,000 | -38.3% | 5.40% | +34.7% |
Q2 2023 | $12,978,000 | +4.7% | 1,030,000 | +8.4% | 4.01% | -11.5% |
Q1 2023 | $12,397,500 | -1.7% | 950,000 | +32.9% | 4.53% | -30.2% |
Q4 2022 | $12,612,600 | +20.9% | 715,000 | +4.4% | 6.50% | +6.0% |
Q3 2022 | $10,433,000 | +27.9% | 685,000 | +24.5% | 6.13% | +29.8% |
Q2 2022 | $8,157,000 | +81.1% | 550,000 | +175.0% | 4.72% | +121.4% |
Q1 2022 | $4,504,000 | +22.1% | 200,000 | 0.0% | 2.13% | +40.5% |
Q4 2021 | $3,690,000 | -52.0% | 200,000 | -65.2% | 1.52% | -37.5% |
Q3 2021 | $7,688,000 | -7.7% | 575,000 | +27.8% | 2.43% | +2.9% |
Q2 2021 | $8,330,000 | -36.6% | 450,000 | -48.6% | 2.36% | -12.4% |
Q1 2021 | $13,138,000 | -39.2% | 875,000 | -41.7% | 2.70% | -40.1% |
Q4 2020 | $21,593,000 | +39.6% | 1,500,000 | -21.1% | 4.50% | -5.6% |
Q3 2020 | $15,466,000 | +42.8% | 1,900,000 | +18.8% | 4.77% | +58.0% |
Q2 2020 | $10,832,000 | -45.2% | 1,600,000 | -43.1% | 3.02% | -59.7% |
Q1 2020 | $19,782,000 | -43.7% | 2,810,000 | -23.0% | 7.49% | -6.7% |
Q4 2019 | $35,150,000 | -24.2% | 3,650,000 | -13.6% | 8.03% | -33.6% |
Q3 2019 | $46,391,000 | +1.5% | 4,225,000 | +7.6% | 12.09% | -13.1% |
Q2 2019 | $45,726,000 | +35.0% | 3,925,000 | +10.6% | 13.90% | +3.4% |
Q1 2019 | $33,867,000 | +15.2% | 3,550,000 | +16.4% | 13.44% | +12.1% |
Q4 2018 | $29,402,000 | +11.2% | 3,050,000 | +56.4% | 11.99% | +58.8% |
Q3 2018 | $26,442,000 | +37.7% | 1,950,000 | +21.9% | 7.55% | +17.5% |
Q2 2018 | $19,200,000 | +5.4% | 1,600,000 | +8.5% | 6.43% | -25.8% |
Q1 2018 | $18,216,000 | -8.9% | 1,475,000 | +7.3% | 8.66% | -20.7% |
Q4 2017 | $20,006,000 | -4.7% | 1,375,000 | -6.8% | 10.92% | -15.0% |
Q3 2017 | $20,989,000 | +31.6% | 1,475,000 | +18.0% | 12.85% | +38.0% |
Q2 2017 | $15,950,000 | +30.4% | 1,250,000 | +29.5% | 9.31% | +21.8% |
Q1 2017 | $12,236,000 | +56.7% | 965,000 | +26.1% | 7.64% | +38.4% |
Q4 2016 | $7,811,000 | -76.6% | 765,000 | -70.2% | 5.52% | +5.0% |
Q3 2016 | $33,448,000 | +160.8% | 2,570,000 | +154.5% | 5.26% | +6.9% |
Q2 2016 | $12,827,000 | -41.2% | 1,010,000 | -38.8% | 4.92% | -35.5% |
Q1 2016 | $21,797,000 | -23.4% | 1,650,000 | -10.8% | 7.63% | +103.7% |
Q4 2015 | $28,453,000 | – | 1,850,000 | – | 3.74% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |